中文 | English
Return
Total: 8 , 1/1
Show Home Prev Next End page: GO
Author:( Yabing CAO)

1.long-term outcome and prognostic factors of nasopharyngeal carcinoma treated by intensity modulated radiotherapy

Guangli XIAO ; Xibin QIU ; Weihua WANG ; Yabing CAO ; Yufeng WANG

Chinese Journal of Radiation Oncology 2012;(6):488-491

2.Analysis of late toxicities after intensity-modulated radiotherapy in 176 patients with nasopharyngeal carcinoma

Gongli XIOA ; Weihua WANG ; Xibin QIU ; Yabing CAO ; Yufeng WANG

Chinese Journal of Radiation Oncology 2013;(1):42-45

3.The role of P53, Bax, Bcl-2 expression and cell apoptosis in the formation and development of acute radiation-induced skin ulcers

Qingyang GU ; Weihong, CAO ; Dewen, WANG ; YaBing, GAO ; Zhixiang YANG ; Po, ZHAO

Bulletin of The Academy of Military Medical Sciences 2001;25(2):103-106

4. Changes in endoplasmic reticulum stress in spinal cord of rats with diabetic neuropathic pain

Jie WU ; Gaili JIA ; Jiahui LU ; Yabing ZHU ; Jun LI ; Hong CAO

Chinese Journal of Anesthesiology 2019;39(8):944-947

5.Research on the Construction of TCM Health Intervention Knowledge Base of Female

Xin CHEN ; Zheng CAO ; Seqi LIN ; Yabing LOU ; Hui JIAN ; Aiping LV ; Qinglin ZHA

World Science and Technology-Modernization of Traditional Chinese Medicine 2018;20(10):1798-1802

6.Study on Losses and Gains of Medical Insurance Funds Induced by Essential Medicine System in a County

Ge BAI ; Zhaohua HUO ; Shiying HE ; Yabing ZHANG ; Wanying LI ; Shuai ZHOU ; Xiaolin CAO ; Tiantian ZHANG ; Ruiming DAI ; Yinan ZHOU ; Liang ZHOU ; Xuechen XIONG ; Li LUO

China Pharmacy 2018;29(11):1441-1444

7.Lung Cancer Screening Study in Macao Smoking Individuals.

Xiaozhan ZHANG ; Chunwing CHEUNG ; Kun CHENG ; Zhenyong YANG ; Weiguo ZHU ; Waiman CHAO ; Siochongdavid LAM ; Yabing CAO ; Mu LI

Chinese Journal of Lung Cancer 2021;24(8):548-556

8.Dose-Dense Rituximab-CHOP versus Standard Rituximab-CHOP in Newly Diagnosed Chinese Patients with Diffuse Large B-Cell Lymphoma: A Randomized, Multicenter, Open-Label Phase 3 Trial

Xueying LI ; He HUANG ; Bing XU ; Hongqiang GUO ; Yingcheng LIN ; Sheng YE ; Jiqun YI ; Wenyu LI ; Xiangyuan WU ; Wei WANG ; Hongyu ZHAN ; Derong XIE ; Jiewen PENG ; Yabing CAO ; Xingxiang PU ; Chengcheng GUO ; Huangming HONG ; Zhao WANG ; Xiaojie FANG ; Yong ZHOU ; Suxia LIN ; Qing LIU ; Tongyu LIN

Cancer Research and Treatment 2019;51(3):919-932

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 8 , 1/1 Show Home Prev Next End page: GO